Abstract:Congenital heart disease (CHD) is the most prevalent type of birth defect in humans and is the leading non-infectious cause of infant death worldwide. There is a growing body of evidence demonstrating that genetic defects play an important role in the pathogenesis of CHD. However, CHD is a genetically heterogeneous disease and the genetic basis underpinning CHD in an overwhelming majority of patients remains unclear. In this study, the coding exons and splice junction sites of the TBX1 gene, which encodes a T-box homeodomain transcription factor essential for proper cardiovascular morphogenesis, were sequenced in 230 unrelated children with CHD. The available family members of the index patient carrying an identified mutation and 200 unrelated ethnically matched healthy individuals used as controls were subsequently genotyped for TBX1. The functional effect of the TBX1 mutation was predicted by online program MutationTaster and characterized by using a dual-luciferase reporter assay system. As a result, a novel heterozygous TBX1 mutation, p.Q277X, was identified in an index patient with double outlet right ventricle (DORV) and ventricular septal defect (VSD). Genetic analysis of the proband's available relatives showed that the mutation co-segregated with CHD transmitted in an autosomal dominant pattern with complete penetrance. The nonsense mutation, which was absent in 400 control chromosomes, altered the amino acid that was completely conserved evolutionarily across species and was predicted to be disease-causing by MutationTaster. Biochemical analysis revealed that Q277X-mutant TBX1 lost transcriptional activating function when compared with its wild-type counterpart. This study firstly associates TBX1 loss-of-function mutation with enhanced susceptibility to DORV and VSD in humans, which provides novel insight into the molecular mechanism underlying CHD and suggests potential implications for the development of new preventive and therapeutic strategies for CHD.

Novel PITX2c Loss-of-function Mutations Associated with Complex Congenital Heart Disease.

Prevalence and Spectrum of PITX2c Mutations Associated with Congenital Heart Disease.

PITX2c Loss-of-function Mutations Responsible for Congenital Atrial Septal Defects.

PITX2 Loss-of-Function Mutation Contributes to Congenital Endocardial Cushion Defect and Axenfeld-Rieger Syndrome.

PITX2 Loss-of-function Mutation Contributes to Tetralogy of Fallot

A Novel TBX1 Loss-of-Function Mutation Associated with Congenital Heart Disease.

Novel GATA6 Mutations Associated with Congenital Ventricular Septal Defect or Tetralogy of Fallot.

A Novel NKX2-5 Mutation in Familial Ventricular Septal Defect.

A Novel Nkx2.6 Mutation Associated with Congenital Ventricular Septal Defect

A HAND2 Loss-of-Function Mutation Causes Familial Ventricular Septal Defect and Pulmonary Stenosis

A Novel NR2F2 Loss-of-function Mutation Predisposes to Congenital Heart Defect.

A New TBX5 Loss-of-Function Mutation Contributes to Congenital Heart Defect and Atrioventricular Block

Novel mutations of TCTN3/LTBP2 with cellular function changes in congenital heart disease associated with polydactyly

A Novel Gata4 Mutation Responsible for Congenital Ventricular Septal Defects

Prevalence and Spectrum of Nkx2.6 Mutations in Patients with Congenital Heart Disease.

Prenatal detection of novel compound heterozygous variants of the PLD1 gene in a fetus with congenital heart disease

TBX20 Loss-of-function Mutation Contributes to Double Outlet Right Ventricle.

A Novel HAND2 Loss-of-function Mutation Responsible for Tetralogy of Fallot.

A New ISL1 Loss-of-Function Mutation Predisposes to Congenital Double Outlet Right Ventricle.

A Novel MEF2C Loss-of-Function Mutation Associated with Congenital Double Outlet Right Ventricle

TBX1 Loss-of-function Mutation Contributes to Congenital Conotruncal Defects